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The prevalence of systemic vasculitis (SV) is steadily 
rising in the world, accounting 2-3 cases per 10 thou-
sand population [8,14]. Currently, the study of SV refers 
to the most dynamically developing areas of rheumatol-
ogy, while emphasizing both the clinical and pathogenetic 
commonality of these diseases, and certain differences of 
separate nosological forms [1,2,10]. Differential diagno-
sis is rather complicated, because the clinical symptoms 
of SV are characterized by the presence of “crossed syn-
dromes” [3]. 
The articular syndrome is one of the main signs of 
Takayasu’s arteritis (TAA) [5], microscopic polyangiitis 
(MPA) [20], Wegener’s granulomatosis with polyangi-
itis (GPA) [16,17], cryoglobulinemic vasculitis (CGV) 
[12,19]. Joint damage in the form of arthritis or arthralgia 
is observed in 65-70% of the patient number with eosino-
philic granulomatosis with polyangiitis, Churg-Strauss 
syndrome (EPA) [9], in 40-50% of CGV [18], in 45-65% 
of Henoch-Shonlein purpura (HSP) [4,6,15], the knee and 
ankle joints are involved in the pathological process most 
often [7]. In MPA, the number of patients with muscu-
loskeletal changes increases within the first 5 years af-
ter debut of the disease, when, among other things, the 
decrease in periarticular bone mineral density begins to 
develop [11]. 
It should be noted that in the contemporary literature, 
only the frequency of arthropathy in patients with SV is 
noted. The purpose and objectives of this study are the re-
search of separate joint lesion in TAA, MPA, GPA, EPA, 
HSP, CGV and polyarteriitis nodosa (PAN), their X-ray 
sonographic characteristics, the relationship between se-
verity of articular syndrome and extraarticular manifesta-
tions of diseases, and the aspects of the arthritis pathogen-
esis in such category of patients.
Material and methods. Under supervision were 525 
patients with SV, the characteristics of which are present-
ed in Table. 1. The ratio of the patients’ number with HSP, 
MPA, CGV, PAN, TAA, GPA and EPA was 7: 4: 3: 1: 1: 1: 
1. According to the generally recognized Chapel Hill no-
menclature (USA, 2012), TAA refers to SV of large-ves-
sels, PAN-medium. Small vessel vasculitis includes GPA, 
EPA and HSP, which is characterized by IgA-dominant 
immune deposits in the small blood vessels, and CGV, in 
which cryoglobulin immune deposits are responsible for 
small blood vessel vasculitis What is more, MPA, GPA 
and EPA are associated with antineutrophil cytoplasmic 
antibodies, HSP and CGV are immune complex SV [13]. 
Women tend to prevail in TAA, men – in PAN, at a ratio 
of 3: 1 and 2: 1 respectively, younger age patients were 
with HSP, and older - with CGV. It should be emphasized 
that the clinical characteristics of patients are presented at 
the time of their examination. So, at the previous stages, 
all examined with MPA, HSP and CGV had skin changes, 
93% with HSP - joint syndrome. In cases of PAN, MPA 
and CGV, peripheral nervous system lesions (mono- and 
polyneuropathy, radiculopathy, and motron metatarsal-
gia) were exceeded, and the central nervous system le-
sions (discirculatory encephalopathy, cerebral circulation 
violation, corticoneural and pseudobulbar syndromes) 
prevailed in patients with TAA and GPA. 55% of TAA 
patients had aortic heart disease, 17% had myocardial in-
farction, 21% - a cerebral stroke. 36% patients with PAN 
were carriers of viral hepatitis B antigen (HBV), and 29% 
patients with CGV - hepatitis C (HCV). Cryoglobulins 
were detected in 97% of the patients with CGV at the 
time of the examination, increased level of immunoglobu-
lin (Ig) A - in 72% of the patients with HSP, antineutro-
phil cytoplasmic antibodies - in 75% with GPA, in 71% 
with MPA and 57% with EPA (the ratioes of antibodies to 
myeloperoxidase and proteinase-3 were 1: 6, 2: 1 and 8: 
1 correspondingly). The level of eosinophils in blood of 
the patients with EPA was 15.1±2.12% of the number of 
white blood cells or 2.1±0.82 109/l.
X-ray examination of peripheral joints, sacroiliac 
joints, spine and lungs was performed on the “Multix-
Compact-Siemens” apparatus (Germany), ultrasound 
examination of joints and internal organs - on “Envi-
sor-Philips” (Netherlands), electrocardiographic - on 
«MIDAC-EK1T» (Ukraine) and «Bioset-8000» (Ger-
many), echocardiographic - on «HD-11-XE-Philips» 
(Netherlands), spirographic - on «Master -Scope-Jaeger 
»(Germany), study of the alveolar-capillary membrane – 
on «Master-Screen-Body-Jaeger »(Germany). “BS-200” 
and “Olympus-AU640” analyzers (Japan), “PR2100-
Sanofi diagnostic Pasteur” reader (France), immunoblot 
“Euroline-Euroimmun” (Germany), computer tensiom-
eters «ADSA-Toronto» (Germany-Kana-da) and «PAT2-
Sinterface» (Germany) were used to evaluate the labora-
tory indices. 
The number of painful joints (NPJ), the Lunsbury in-
dices (iL), iDAS and iDAS28 were estimated, the inte-
grated severity of arthropathy index (iSA) were calculated 
by the formula:
iSA = √iL • DAS.
The statistical processing of the obtained research re-
sults was carried out using a computer variational, non-
parametric, correlation, one (ANOVA) and multivariate 
(ANOVA / MANOVA) dispersion analysis (programmes 
“Microsoft Excel and Statistica-Stat-Soft», USA). Mean 
values (M), their standard errors (m), standard deviations 
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(SD), correlation coefficients, dispersion criteria, Student, 
Wilcoxon-Rao, McNamara-Fischer and reliability of sta-
tistical indicators were estimated.
Results and their discussions. Such joint lesions as 
arthritis or arthralgia, are noted in 32% of patients with 
GPA, in 41% patients with TAA, 47% - with HSP, 52% 
- with PAN, 63% - with MPA and EPA, 67% - CGV, and 
monoaligoarthritis - in 33; 50; 54; 25; 58; 18 and 50% of 
observations respectively. According to the one-factor dis-
persion analysis, the development of articular syndrome 
in MPA is influenced by changes in skeletal muscles and 
lungs, in GPA – by the duration of the disease, changes 
in the skin, heart and liver, in HSP – by the age of the 
patients, degree of the pathological process activity, skin 
lesions and kidneys, in EPA - only by skin syndrome, in 
CGV – by myositis/myalgia, pneumopathy and nephropa-
thy. The occurrence of arthropathy depends on the sever-
ity of extra-articular manifestations of PAN, MPA, GPA, 
HSP, CGV.
Taking into account the frequencies of arthropathy 
formation in MPA and CGV, we conducted an addition-
al analysis. It turned out that the articular syndrome in 
patients with MPA is reliably affected by the indicators 
of the ratio between systolic pressure in the pulmonary 
artery to the peripheral arterial pressure and diffusion ca-
pacity of the lungs, and in cases of CGV - parameters of 
pulmonary vascular resistance and end diastolic volume 
of the right ventricle.
As demonstrated by the performed ANOVA, the char-
acter of articular syndrome in TAA depends on the param-
eters of fibrinogen in blood, in PAN - on the concentration 
of circulating immune complexes and antibodies to native 
deoxyribonucleic acid (aDNA), in MPA - on the level of 
antibodies to proteinase-3, in GPA - on the content of the 
latter and the values  of fibronectin in blood, in EPA - on 
C-reactive protein indications in blood and the presence 
of antibodies to myeloperoxidase, in HSP - on parameters 
of IgA, indices of platelet and red blood cells aggregation, 
thromboxane A2, prostacyclin and prostaglandin E2, in 
CGV - on tumor necrosis factor-γ, endothelin-1 and pros-
taglandin F
2a
. It is necessary to emphasize that in PAN 
there is a significant influence HBV-carrier on the devel-
opment of joint lesions. In such patients, the joint syn-
drome is detected in all cases, whereas it is only in 48% of 
cases without HBV (the differences are high-significant).
The frequency of the separate joint involvement in 
the pathological process and the presence of X-ray so-
nography signs of arthropathy are represented in gener-
alized form in table. 2,3 at that features of the articular 
syndrome in patients with different variants of SV have 
been revealed. For EPA, there were typical lesions of 
vertex and sternoclavicular joints, for AAT - proximal in-
terphalangeal joints of hand, humeral and knee articula-
tions, for PAN - ulnar and metatarsophalangeal, for MPA 
- wrist and ankle, for CGV - sacroiliac and vertebra. In 
turn, the changes in the sternoclavicular junctions refer to 
the “joints-exclusion” in AAT, GPA and CGV, ankle, sac-
roiliac and vertebrae – in GPA, elbow – in TAA, shoulder 
–in EPA and CGV.
There are typical changes in meniscus horns and the 
presence of intra-articular bodies of Pellagri-Shtaydi and 
Hoff for TAA, and Baker cysts - for PAN. Tendovaginitis 
Table 1. Characteristics of the examined patients with SV
Indices
Group of patients with SV (n=525)
TAA PAN MPA GPA EPA HSP CGV
Number of patients in groups 29 39 116 28 27 193 93
Men/women % 24/76 62/38 41/59 57/43 44/56 51/49 41/59
Age (M±m), years 44,2±2,48 44,2±1,88 44,8±1,23 46,0±2,41 40,4±2,59 26,2±0,72 52,3±1,28
Duration of the disease
(M±m, years)
10,4±1,98 8,5±1,30 6,4±0,70 4,3±0,83 10,7±2,05 9,0±0,60 4,6±0,62
 II-III stage of activity, % 86 79 85 93 85 72 92
Acute course, % – 15 28 56 – 19 43
Signs of lesion, % 
skin
skeletal muscle
heart
liver
spleen
nervous system
kidney
17
48
76
28
4
21
62
31
54
80
56
13
90
62
82
38
51
56
8
48
67
21
36
50
46
7
46
64
52
37
48
33
19
37
56
64
15
31
22
7
18
67
85
26
61
62
25
40
68
Kidney failure, % 35 26 35 29 26 18 32
Glomerular filtration rate, 
ml/min
107,1
±4,78
104,4
±4,18
101,2
±2,51
108,2
±3,99
110,5
±4,34
110,3
±1,92
103,3
±2,68
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can be considered typical for PAN and CGV, subchondral 
sclerosis and osteocystosis - for patients with GPA and 
EPA. It is noted the absence of cases of tendovaginitis and 
entesopathy in TAA and MPA, and on the whole a scanty 
variety of “x-ray sonographic landscape of articular syn-
drome” in cases of GPA.
According to the multifactorial analysis of Wilcoxon-
Rao, the character of the arthropathy course in patients 
with MPA depends on the lung and heart lesions, in the 
case of HSP - on the involvement of lung and liver, in 
CGV - on renal pathology and integral gravity of extraar-
ticular signs of the disease. As ANOVA / MANOVA tes-
tifies, the integral X-ray and sonographic signs of joint 
changes in patients with PAN depend on the disease ac-
Table 2. Typical and atypical signs of arthropathy in patients with SV
TAA PAN MPA GPA EPA HSP CGV
1 ⊕ ⊗
2 ⊗ ⊗ ⊕ ⊗
3 ⊕
4
5 ⊕ ⊕
6 ⊗ ⊕ ⊕
7 ⊕ ⊗ ⊗
8
9 ⊕
10 ⊕ ⊗
11 ⊕
12
13 ⊗ ⊕
14 ⊗ ⊗ ⊕
Joints: 1 - maxillary; 2 - sternoclavicular; 3 - proximal interphalangeal of hands; 4 - metacarpophalangeal; 
5 - wrist; 6 - ulnar; 7 - humeral; 8 - proximal interphalangeal of foot; 9 - metatarsophalangeal; 
10 - ankle; 11 - knee; 12 - hip; 13 - sacroiliac; 14 - vertebrae. Å - typical signs; Ä - absence of signs
Table 3 Typical and atypical symptoms of musculoskeletal system lesions in patients with SV
TAA PAN MPA GPA EPA HSP CGV
I ⊗ ⊕ ⊗ ⊕
II ⊗ ⊗ ⊗
III
IV ⊕ ⊗ ⊕
V ⊕ ⊕ ⊗
VI ⊗ ⊗ ⊗ ⊗
VII ⊗ ⊗
VIII ⊗ ⊗ ⊗
IX ⊗ ⊗
X ⊕ ⊕ ⊗
XI ⊗ ⊗
XII ⊕ ⊗
XIII ⊗
XIV ⊕
Symptoms: I - tendovaginitis; II - enthesopathy; III - epiphyseal osteoporosis; IV - subchondral sclerosis; 
V - osteocystis; VI - osteousuras; VII - ligamentosis; VIII - aseptic necrosis; IX - arthrocalcinates; 
X - changes in the meniscus; XI - Baker’s cysts; XII - bodies of Pellagri-Shtaydi; XIII - chondromic bodies; 
XIV - the bodies of Hoff; Å - a typical symptom; Ä - absence of a symptom
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tivity degree and the severity of extraarticular manifesta-
tions, with MPA - on the nature of nephropathy, and with 
HSP - pneumopathy.
As performed by ANOVA, the age of patients with 
TAA, PAN, MPA and EPA affects the frequency of the 
maxillary articulation lesions. The changes in proximal 
interphalangeal joints of brushes closely related with the 
age of the patients with TAA, knee joints - with PAN, 
sternoclavicular, wrist and proximal interphalangeal feet - 
with MPA, wrist and shoulder - with HSP. The presence of 
cardiopathy (disturbance of myocardial excitability, elec-
trical conduction of the heart, changes in the myocardium, 
endocardium and cardiac valves, diastolic and systolic 
dysfunction of the left ventricle) have a dispersive effect 
on the lesions of proximal interphalangeal joints of the 
fingers, wrist and ankle in patients with TAA, but only on 
the wrist - with CGV. Metatarsophalangeal articulation le-
sion in TAA depend on the nature of nephropathy (urinary 
or nephrotic syndrome, the condition of kidney function), 
in the case of PAN - wrist, CGV - proximal interphalan-
geal foot and hip.
The origin of tendovaginitis in PAN and EPA is close-
ly related to hepatic pathology, entesopathy in MPA and 
HSP - to renal disease. The appearance of intraarticular 
bodies (chondromic, Pellagri-Shtaydi, Hoff) occurs in 
parallel with an increase of the disease duration in TAA 
patients, and they are determined by the severity of the 
skin-muscular syndrome in PAN patients. Bone-destruc-
tive signs of the musculoskeletal system disorders depend 
on extraarticular manifestations of SV. It should be noted 
that Baker’s cysts in MPA and lesions of the maxillary 
joints in HSP are observed exclusively in men, whereas 
the incidence of lesions of proximal interphalangeal joints 
of brushes and metacarpophalangeal joints in patients 
with HSP significantly prevails in the female group, re-
spectively in 3,7 and 3.2 times.
As can be seen from Table. 4, the greatest number 
of painful joints (NPJ) is peculiar to patients with GPA, 
and the greater integral severity of the joint syndrome is 
typical for patients with TAA. According to the dispersion 
analysis, parameters of NPJ in PAN are closely related to 
the severity of skin lesions, in MPA - to acute course of 
the disease, in HSP - to changes in the nervous system and 
in CGV - to severity of hepatic pathology.
The degree of severity of articular syndrome assessed 
by iSA, in PAN and HSP depends on the functional state 
of the kidneys, in MPA and HSP - on the integral sever-
ity of the extraarticular signs of the disease. In addition, 
iSA is affected by the overall disease activity in the group 
of patients with HSP. Whereas the severity of arthropathy 
grows with an increase in the duration of MPA course, 
then in patients with HSP its decreases (Fig. 1). In turn, in 
both groups of SV patients, iSA grows, according to the 
increase in the integrated severity of extrarenal manifesta-
tions of diseases (Fig. 2). 
 
Fig. 1. The relationship between iSA indicators with MPA 
duration (red curves) and HSP (blue)
Fig. 2. The relationship between iSA indicators and the 
severity of MPA symptoms (red curves) and HSP (blue)
The prevalence of articular syndrome in patients with 
TAA is significantly influenced by the indices of circu-
Table 4. Indices of joint syndrome in patients with SV (M±m)
SV
Index
NPJ, abs IL, balls iDAS, r.u. iDAS 28, r.u. iWA, r.u.
TAA 10,6±3,10 78,7±14,38 2,4±0,50 3,4±0,51 22,7±6,10
PAN 11,9±2,68 60,6±9,30 2,2±0,32 2,9±0,32 19,3±4,25
MPA 8,5±1,38 58,7±4,85 1,7±0,19 2,7±0,20 15,0±2,29
GPA 14,4±4,79 48,0±17,07 2,3±0,62 3,3±0,67 18,8±8,33
EPA 13,1±2,91 60,8±12,12 2,0±0,27 2,9±0,29 16,7±4,11
HSP 7,7±0,87 60,8±4,54 1,5±0,18 2,5±0,19 13,9±2,10
CGV 7,3±1,32 53,8±4,37 1,2±0,09 2,2±0,10 9,5±1,26
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lating immune complexes in blood and antibodies to 
cardiolipin, with MPA – by levels of rheumatoid factor 
(RF), fibrinogen, aDNA, endothelin-1, homocysteine  and 
module of viscoelasticity of blood serum, with GPA – by 
concentration of RF, antibodies to myeloperoxidase, IgG, 
cyclic guanosine monophosphate and surface viscosity of 
blood, with HSP - aDNA, anti-cardiolipin and tumor ne-
crosis factor-α, with CGV - RF and IgM. The severity of 
the joint syndrome course in cases of AAT, PAN and MPA 
is associated with the seropositivity of the diseases by RF, 
GPA - with the presence of antibodies to proteinase-3, 
EPA - with the content of fibronectin, HSP - with levels 
of IgA, b2-microglobulin and RF, CGV - with bulk vis-
cosity, surface elasticity, relaxation with thromboxane A2. 
According to the correlation analysis, iSA index directly 
relates to RF parameters in blood in patients with MPA, 
and vice versa - with its viscoelasticity, and in patients 
with HSP - to IgA concentration, with CGV - to the level 
of thromboxanemia.
Taking into account the statistical processing of the 
obtained results of studies, relevant conclusions having 
a certain practical importance have been made: 1) prog-
nostic factors with respect to the frequency of develop-
ment and course of joint pathology in patients with PAN 
are HBV-carrier, and in MPA, HSP and CGV - severity 
of extraarticular signs of diseases; 2) RF parameters in 
blood in TAA, PAN, MPA, HSP and CGV > 20 IU / ml (> 
M±SD patients with SV) are considered risk factors for 
the severe course of arthropathy.
Conclusion. Such joint damage as arthritis or arthral-
gia is revealed in 32% of patients with GPA, 41% - with 
AAT, 47% - with HSP, 52% - PAN, 63% - MPA and EPA, 
67% - CGV, which has gender differences, depends on 
the duration of the disease, the degree of activity of the 
pathological process, the severity of extra-articular signs, 
lung function and the state of hemodynamics in the lesser 
circulation, the frequency of lesions of individual bone 
articulations, tendovaginitis, enthesopathy and X-ray so-
nography signs of the joint syndrome. There has been its 
own dimorphism in different nosologies, in patients with 
PAN it is associated with the carriage of HBV, and in the 
pathogenetic constructs of arthropathy in SV there are 
disorders of the immunity system (immuno-inflammatory 
proteins, cytokines, various antibodies), rheological prop-
erties of blood and endothelial functions of blood vessels. 
And the high RF parameters in blood are risk factors for 
the severe course of joint damage in cases of TAA, PAN, 
MPA, HSP and CGV.
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SUMMARY
CHARACTERISTICS OF ARTICULAR SYN-
DROME IN SYSTEMIC VASCULITIS 
1Syniachenko O., 2Khaniukov O., 2Yehudina Ye., 
1Taktashov H., 2Gashynova K.
1Donetsk National Medical University of Health Ministry of 
Ukraine, Lyman; 2State Institution “Dnipropetrovsk Medical 
Academy of the Ministry of Health of Ukraine", Ukraine
The purpose of the study – investigation the separate 
joint lesion in systemic vasculitis, their X-ray sonographic 
characteristics, the correlation of the articular syndrome 
severity with extra-articular manifestations of the diseas-
es, as well as aspects of the arthritis pathogenesis in this 
category of patients. 
The study included 525 patients in the ratio of the ex-
amined with Henoch-Schonlen purpura, microscopic poly-
angiitis, cryoglobulinemic vasculitis, polyarteritis nodosa, 
Takayasu’s arteritis, Wegener’s granulomatosis with poly-
angiitis and eosinophilic granulomatosis with polyangiitis 
Churg-Strauss as a 7:4:3:1:1:1:1. Joint’s damage in the form 
of arthritis or arthralgia observed in 32-67% different groups 
of patients, that depending on the disease duration, the de-
gree of the pathological process’s activity, extraarticular 
signs severity, lung parenchyma involving and hemodynam-
ic status in the pulmonary circulation. The frequency of the 
certain bone lesions, existence of tenosynovitis and enthe-
sopathies, X-ray sonographic signs of articular syndrome in 
different kind of vasculitis has its own gender dimorphism. 
The immune system malfunction, the rheological properties 
of blood and endothelial function of vessels collaborate in 
pathogenetic constructions of arthropathy. What is more, 
the high value of rheumatoid factor in blood associates with 
severe course of joint damage. Joint syndrome at different 
variants of systemic vasculitis is progressing in 1/3-2/3 of 
cases, this syndrome has definite features of clinical course 
and pathogenesis. 
Keywords: vasculitis systemic, joints, clinic, patho-
genesis.
РЕЗЮМЕ
ХАРАКТЕРИСТИКА СУСТАВНОГО СИНДРО-
МА ПРИ СИСТЕМНЫХ ВАСКУЛИТАХ
1Синяченко О.В., 2 Ханюков А.А., 2Егудина Е.Д., 
1Такташов Г.С., 2Гашинова Е.Ю. 
1Донецкий национальний медицинский университет 
МЗ Украины, Лиман; 2ГУ «Днепропетровская меди-
цинская академия МОЗ Украины», Днепр, Украина 
Целью исследования явилось изучение поражения 
отдельных суставов при системных васкулитах, их 
рентгеносонографических особенностей, взаимос-
вязи тяжести артикулярного синдрома с внесустав-
ными проявлениями заболеваний, а также аспектов 
патогенеза артритов у данной категории больных. 
Под наблюдением находилось 525 больных. Соот-
ношение числа обследованных с васкулитом Шен-
лайна-Геноха, микроскопическим полиангиитом, 
криоглобулинемическим васкулитом, узелковым по-
лиартериитом, аортоартериитом Такаясу, гранулема-
тозом с полиангиитом Вегенера и эозинофильным 
гранулематозным полиангиитом Черджа-Стросса со-
ставило 7:4:3:1:1:1:1. Поражение суставов в виде ар-
трита или артралгий наблюдалось у 32-67% больных 
в разных группах. Тип поражения суставов при выше 
перечисленных заболеваниях зависел от длительно-
сти заболеваний, степени активности патологическо-
го процесса, тяжести экстраартикулярных признаков, 
вовлечения в процесс легочной паренхимы и состо-
яния гемодинамики в малом круге кровообращения. 
Частота поражений отдельных костных сочленений, 
наличие тендовагинитов, энтезопатий и рентгеносо-
нографических признаков суставного синдрома при 
разных васкулитах имеет свой гендерный диморфизм. 
В патогенетической этиологии артропатии участву-
ют нарушения иммунной системы, реологических 
свойств крови и эндотелиальной функции сосудов. 
Высокие уровни ревматоидного фактора в крови ас-
социированы с риском развития тяжелого течения су-
ставного синдрома.
Суставной синдром при разных вариантах систем-
ных васкулитов развивается в 1/3-2/3 случаев, имеет 
свои особенности патогенеза и клинического течения. 
reziume
saxsrovani sindromis daxasiaTeba sistemu-
ri vaskulitebis dros
1o. siniaCenko,  2a. xaniukovi, 2e. egudina, 
1g. taktaSovi,  2e. gaSinova
1ukrainis janmrTelobis dacvis saministros 
doneckis erovnuli samedcino universiteti, 
limani; 2ukrainis janmrTelobis dacvis sa-
ministros dnepropetrovskis samedicino aka-
demia, dnepri, ukraina
kvlevis  mizans Seadgenda sistemuri 
vaskulitebis dros calkeuli saxsris 
dazianebis, maTi rentgenosonografiuli 
Taviseburebebis, artikulur sindromsa 
da  daavadebebis arasaxsrovan gamovline-
bebs Soris urTierTkavSiris, aseve, am kate-
goriis pacientebSi arTritis paTogenezis 
aspeqtebis Seswavla. dakvirvebis qveS imyo-
feboda 525 pacienti.
gamokvleul pacientTa Tanafardoba Sen-
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lain-henoxis vaskulitiT, mikroskopiuli 
poliangiitiT, krioglobulinemiuri vasku-
litiT, kvanZovani poliartetiitiT, takaia-
sus aortoarteriitiT, granulomatoziT 
vegeneris poliangiitiT da Cerj-strosis 
granulomatozuri poliangiitiT Seadgenda 
7:4:3:1:1:1:1–s. saxsrebis dazianeba arTritis, 
an arTralgiis saxiT pacientTa sxvada-
sxva jgufSi aRiniSna SemTxvevaTa 32-67%-
Si. saxsrebis dazianebis tipi zemoCamoTv-
lili daavadebebis dros damokidebuli iyo 
daavadebis xangrZlivobaze, paTologiuri 
procesis aqtivobis xarisxze, saxsargare 
niSnebis simZimeze, procesSi filtvis paren-
qimis CarTulobasa da hemodinamikis mdgo-
mareobaze sisxlis mimoqcevis mcire wreSi. 
calkeul ZvalTSesaxsrebis dazianebi six-
Sires, tendovaginitebis, entezopaTiebis da 
saxsrovani sindromis niSnebis arsebobas 
sxvadasxva tipis vaskulitis dros axasi-
aTebs genderuli dimorfizmi. arTropaTi-
is paTogenezur etiologiaSi monawileobs 
darRvevebi imunur sistemaSi, sisxlis re-
ologiur Tvisebebsa da sisxlZarRvebis 
endoTelur funqciaSi. sisxlSi revmatoi-
duli faqtoris maRali maCveneblebi asoci-
rebulia saxsrovani sindromis mZime mimdina-
reobis ganviTarebis riskTan.
saxsrovani sindromi sistemuri vaskuli-
tis sxvadasxva variantis dros viTardeba 
SemTxvevaTa 1/3-2/3-Si, aqvs paTogenezis da 
klinikuri mimdinareobis Taviseburebani.
ASSESSMENT OF NEURODEVELOPMENTAL OUTCOMES IN INFANTS 6-12 MONTHS 
OF AGE ACCORDING TO IMPACT OF PERINATAL RISK FACTORS 
²Tskimanauri N., ¹Khachapuridze N., ³Imnadze P., ²Chanadiri T., ¹Bakhtadze S.
¹Tbilisi State Medical University; ²Neurological Clinic LTD “Valeo”, Tbilisi; 
³I. Javakhishvili Tbilisi State University, Georgia
Infants exposed to some perinatal risk factors are at in-
creased risk of neurodevelopmental problems throughout 
early childhood. Multiple risk factors are associated with 
increased risks of perinatal morbidity and mortality, how-
ever long term neurodevelopmental outcome of survivors 
is poorly described. According to literature data infants 
were significantly more likely to have neurodevelopmen-
tal impairment compared to healthy control infants, when 
assessed at 6-12 months and 2-3 years of age [1,12].
Studies have suggested that some early-childhood 
neurosensory and developmental outcomes for some 
groups of infants, who were born with some neonatal 
pathologies, such as extremely prematurity [4], neonatal 
infections and early-onset sepsis [3], hypoxic-ischemic 
encephalopathy, CNS malformation, intracranial hemor-
rhage [17] and others, thereafter were become critically 
ill during the neonatal period and were treated, but stayed 
at risk for adverse neurodevelopmental outcomes, have 
improved over the last decade. Even so it is not clear 
whether this trend applies to population of infants, who 
born healthy, but had been impacted by pathologies of 
pregnancy/delivery or other perinatal risks.
Authors have usually presented a single-center anal-
ysis, which have shown influence of separate factors 
identified as important risk factors. Major neurologic ab-
normalities, cognitive delays and impairs psychomotor 
development during the first year of life are presented in 
all cases of studied population [17]. There are identified 
significant correlations between these single risk factors, 
related to neonatal pathologies, and neurodevelopmental 
adversities. However, there are no large, recent analyses 
to examine whether neurodevelopmental outcomes im-
proved, worsened, or remained the same for those vulner-
able infants born healthy, but impacted by combination of 
factors and pathological conditions related to their devel-
opment before birth.
Literature was reviewed the associations between 
some maternal pathological conditions exposure during 
pregnancy and labor with child neurodevelopment, which 
were stronger at neonatal period than at older ages. At the 
same time, information about the persistence of this as-
sociation at later ages is limited.
The purpose of this research was: a. assessment of risk 
predictors for adverse neurodevelopmental outcome at age 
of 6 month and 12 month in divided groups of infants, parti-
tion of which had implemented by birth as healthy or with 
neonatal pathologies and b. to report developmental follow-
up data from a case-control prospective study of infants ex-
posed to separate and combination impact of risk factors.
Material and methods. Between January 2015 and 
December 2016, we prospectively enrolled 1018 live-born 
infants, information about which we had received from 
the medical reports of the participating clinics in Tbilisi 
(capital of Republic of Georgia) and Mtskheta, Dusheti 
(districts of Georgia), and included them in the study. 
At the first stage of research it was conducted descrip-
tive population-based prospective pilot study, as a result 
of which: 
